Printer Friendly

Virta Health Launches to Reverse Type 2 Diabetes.

M2 PHARMA-March 9, 2017-Virta Health Launches to Reverse Type 2 Diabetes

(C)2017 M2 COMMUNICATIONS

- US-based online specialty medical clinic Virta Health, a new company founded by a team of physicians, scientists, and technologists trained at Stanford, MIT, and Harvard, has launched with a mission to reverse type 2 diabetes, the company said.

The company's debut comes on the heels of a new peer-reviewed study that demonstrates Virta was successful in reversing type 2 diabetes in half of its clinical trial patients and eliminating or reducing insulin in 87 % of patients in just ten weeks.

Virta said it helps lower hemoglobin A1c (a measure of blood sugar) while reducing or eliminating medications in an online setting with continuous, remote care delivered by a dedicated physician and health coach.

The company is backed by USD 37m in funding from an all-star group of investors including: Venrock, Allen and company, Ev Williams' Obvious Ventures, Redmile Group, and PayPal and Affirm founder Max Levchin's Scifi VC.

Drawing on decades of research, including that of its founders and advisors, Virta is driving two major innovations.

First, Virta's science takes a highly individualised approach to carbohydrate intake and nutritional ketosis (when a body burns fat as its primary fuel source instead of glucose).

And second, Virta's technology platform and artificial intelligence enable continuous, remote care and ongoing personalization of each patient's care plan, delivered online by Virta physicians and health coaches.

Taken together, these innovations enable Virta to deliver the high-engagement, personalized care required to reverse type 2 diabetes safely and sustainably at scale.

The clinic does this by providing physician supervision, a dedicated health coach, app and biomarker tracking tools, a community of peers, and a personalized nutrition and care plan.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2017 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2017 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Mar 9, 2017
Words:298
Previous Article:Warburg Pincus to Invest USD 115m in Alignment Healthcare.
Next Article:Spitzer Joins Innovaccer's Board of Advisors.
Topics:

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters